It appears the FDA aren't convinced it works. The only published RCT says it doesn't. I think I see the problem.
' Remestemcel-L did not meet the primary endpoint of greater DCR in the intent-to-treat population (35% versus 30%; P = 0.42).'
Whats all the whining about?
It appears the FDA aren't convinced it works. The only published...
Add to My Watchlist
What is My Watchlist?
